Shares of Catalyst Pharmaceuticals rose 5.9% to $4.85 at 13:19 EST on Monday, following the last session’s downward trend. NASDAQ Composite is falling 0.26% to $13,925.82, following the last session’s downward trend, This seems, so far, a somewhat rough trend exchanging session today.

Catalyst Pharmaceuticals’s last close was $4.58, 7.01% under its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 3%, now sitting on 119.07M for the twelve trailing months.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $4.85 at 13:19 EST, below its 52-week high of $5.19 and way higher than its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way higher than its 50-day moving average of $4.11 and way above its 200-day moving average of $3.63.

More news about Catalyst Pharmaceuticals.

LEAVE A REPLY

Please enter your comment!
Please enter your name here